Infections and Hospitalizations in Adolescents with Atopic Dermatitis Treated with Oral Janus Kinase Inhibitors: A Cohort Study Using TriNetX - PubMed
5 hours ago
- #JAK inhibitors
- #Adolescent Health
- #Atopic Dermatitis
- Study focuses on infections and hospitalizations in adolescents with atopic dermatitis treated with oral Janus kinase inhibitors (JAKi).
- Utilizes TriNetX for cohort study methodology.
- Keywords include JAK inhibitors, infection risk, and real-world data.
- Specific JAK inhibitors mentioned: abrocitinib, tofacitinib, upadacitinib.
- Published in Journal of the American Academy of Dermatology (JAAD).